Comparison Between Age-Related Macular Degeneration And Polypoidal Choroidal Vasculopathy Using Optical Coherence Tomography
DOI:
https://doi.org/10.54112/bcsrj.v6i4.1702Keywords:
Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy, Optical Coherence Tomography, Choroidal Neovascularization, Macular EdemaAbstract
Age-Related Macular Degeneration (ARMD) and Polypoidal Choroidal Vasculopathy (PCV) are retinal conditions leading to central vision loss, especially in older individuals. Differentiating between these two conditions is critical for proper management, and Optical Coherence Tomography (OCT), particularly with OCT Angiography (OCTA) and Enhanced Depth Imaging (EDI) OCT, plays a key role in their diagnosis. Despite the availability of these advanced imaging techniques, PCV often remains undiagnosed, especially in resource-limited regions. Objective: This study compared the qualitative and quantitative features of ARMD and PCV using OCT and OCTA to enhance our understanding of their differences and promote accurate diagnosis, especially in settings where OCTA is underutilized. Methods: A retrospective study was conducted at Lahore Eye Care Center and Nishtar Hospital, Multan, from February to August 2024. Forty-three patients diagnosed with ARMD and PCV were included. The inclusion criteria required the presence of characteristic OCT findings, while patients with conditions such as diabetic retinopathy or retinal detachment were excluded. OCT measurements of central subfoveal and parafoveal thickness were used to quantify macular changes. Qualitative analysis focused on drusen, retinal pigment epithelium (RPE) elevation, and choroidal neovascularization (CNV) for ARMD and macular thickening and RPE irregularities for PCV. Results: The study revealed that patients with PCV exhibited significantly higher central subfoveal and parafoveal thicknesses than those with ARMD. Central subfoveal thickness in PCV was greater than 290 microns, while in ARMD, it was less than 250 microns. Parafoveal thickness was also thicker in PCV, with values exceeding 290 microns, compared to ARMD, which was below 270 microns. Qualitative features, including irregular RPE and ring-like lesions, were more prominent in PCV. Conclusion: This study demonstrates that OCT and OCTA are invaluable tools in differentiating ARMD from PCV, with distinct differences in qualitative and quantitative features. The findings underscore the need for greater awareness and access to OCTA, particularly in developing countries where PCV remains underdiagnosed. Early and accurate diagnosis through OCT and OCTA can significantly improve management outcomes for patients with these conditions.
Downloads
References
Guymer RH, Franzco P, Wu Z. Age-related macular degeneration (AMD): More than meets the eye. The role of multimodal imaging in today's management of AMD—A review. Clin Exp Ophthalmol. 2020;48(6):823-834.
Guymer RH, Tufail A, Lee WY. Advances in age-related macular degeneration. Clin Exp Ophthalmol. 2020;48(6):857-867.
Teo KYC, Zhao JZ, Klose G, Lee WK, Cheung CMG. Polypoidal Choroidal Vasculopathy: Evaluation Based on 3-Dimensional Reconstruction of OCT Angiography. Ophthalmol Retina. 2023;7(5):390-400.
Wang W, Zeng J, Wei Y. Imaging modalities in the diagnosis of age-related macular degeneration. Ophthalmol Clin North Am. 2021;34(2):223-237.
Lee WK, Yoon YH, Lee JY. Polypoidal choroidal vasculopathy: Clinical characteristics and diagnostic criteria. Br J Ophthalmol. 2020;104(8):1092-1098.
Kim YH, Lee YH, Park YH. Long-term outcomes of photodynamic therapy for polypoidal choroidal vasculopathy. Ophthalmology. 2020;127(7):907-915.
Klose G, Cheung CMG, Lee WK, Teo KYC. Advances in OCTA and EDI OCT in Retinal Imaging. Retina. 2023;43(3):541-552.
Dey S, Gupta M, Agarwal A. OCTA: Current perspective in diagnosing retinal diseases. J Clin Diagn Res. 2021;15(2):7-11.
Yu S, Zhang X, Li X. Role of OCT and OCTA in managing age-related macular degeneration. Asia Pac J Ophthalmol. 2022;11(3):137-146.
Lee M, Kang E, Kim H, et al. Early detection and management of polypoidal choroidal vasculopathy. Int Ophthalmol. 2023;43(4):1267-1275.
Guymer RH, Franzco P, Wu Z. Age-related macular degeneration (AMD): More than meets the eye. The role of multimodal imaging in today's management of AMD—A review. Clin Exp Ophthalmol. 2020;48(6):823-834.
Teo KYC, Zhao JZ, Klose G, Lee WK, Cheung CMG. Polypoidal Choroidal Vasculopathy: Evaluation Based on 3-Dimensional Reconstruction of OCT Angiography. Ophthalmol Retina. 2023;7(5):390-400.
Lee WK, Yoon YH, Lee JY. Polypoidal choroidal vasculopathy: Clinical characteristics and diagnostic criteria. Br J Ophthalmol. 2020;104(8):1092-1098.
Kim YH, Lee YH, Park YH. Long-term outcomes of photodynamic therapy for polypoidal choroidal vasculopathy. Ophthalmology. 2020;127(7):907-915.
Kim YH, Oh JY, Lee SM, et al. Comparison of Optical Coherence Tomography Angiography and Fluorescein Angiography in Polypoidal Choroidal Vasculopathy. Am J Ophthalmol. 2020;215:26-35.
Klose G, Cheung CMG, Lee WK, Teo KYC. Advances in OCTA and EDI OCT in Retinal Imaging. Retina. 2023;43(3):541-552.
Lee M, Kang E, Kim H, et al. Early detection and management of polypoidal choroidal vasculopathy. Int Ophthalmol. 2023;43(4):1267-1275.
Yu S, Zhang X, Li X. Role of OCT and OCTA in managing age-related macular degeneration. Asia Pac J Ophthalmol. 2022;11(3):137-146.
Dey S, Gupta M, Agarwal A. OCTA: Current perspective in the diagnosis of retinal diseases. J Clin Diagn Res. 2021;15(2):7-11.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Seemal Masood, Muhammad Rashad Qamar Rao, Fatima Tayab, Rai Farooq Ur Rehman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.